In the present study, we successfully showed that HMF administered p.o. also ameliorated CUMS-induced depression-like pathologies (body weight loss; Figure 3, and prolonged immobility in FST; Figure 5) and hippocampal reductions in BDNF expression (Figure 6 and Figure 7). This evidence concerns the gene BDNF and major depressive disorder.